Skip to main content

Early detection of cervical cancer in hard-to-reach populations of women through portable and point-of-care HPV testing

Objective

Cervical cancer is the 4th most common cancer in women worlThe ELEVATE project sets a multidisciplinary team comprising manufactures and experts from Europe and the Community of Latin American and Caribbean States, to improve the global adequacy and coverage of cervical cancer screening, particularly to specific populations of women that by not being regularly screened (hard-to-reach populations) are at higher-risk to develop cervical cancer. Although Cervical cancer is still the fourth most common cancer in women worldwide, with up to 85% of the burden occurring in developing countries, preventive vaccination against human papillomavirus and early detection of precancer in screening programs has shown to be successful in reducing cancer incidence and mortality.1–3 However, different challenges hamper a global implementation of such programs and are in the base of women’s non-attendance to screening. This highlights the lack of reflection of ethnic, cultural and resource differences from different populations in current cervical cancer screening. In ELEVATE it is proposed to conduct social science investigations to identify hard-to-reach women in Belgium, Brazil, Ecuador and Portugal, to address their barriers to screening and to design strategies to make primary screening more accessible to them, and therefore, contribute to reduce the global burden of cervical cancer. This will be complemented with fundamental and technological research to develop an efficient and marketable test for the combined genomic and proteomic detection of high-risk HPV infections in those populations. The test will be made portable, low-cost, compatible with self-sampling, point-of-care and generate rapid and easy-to-understand results, without relying on electrical outlets or trained health personnel. Integrant part of the proposal is also to infer and disseminate the societal, economic implications of the developed strategies using a hard-to-reach community-based participatory research.

Call for proposal

H2020-SC1-2018-Single-Stage-RTD
See other projects for this call

Funding Scheme

RIA - Research and Innovation action

Coordinator

UNIVERSITEIT GENT
Address
Sint Pietersnieuwstraat 25
9000 Gent
Belgium
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 1 518 835

Participants (8)

UNIVERSIDADE NOVA DE LISBOA
Portugal
EU contribution
€ 419 850
Address
Campus De Campolide
1099 085 Lisboa
Activity type
Higher or Secondary Education Establishments
CONSORCIO DE INVESTIGACION SOBRE VIH SIDA TB CISIDAT
Mexico
EU contribution
€ 0
Address
Av. Teopanzolco 408 Torre C 201 Reforma
62260 Cuernavaca Morelos
Activity type
Research Organisations
UNIVERSIDAD DE CUENCA
Ecuador
EU contribution
€ 259 900
Address
12 Of April Avenue
01.01 Cuenca
Activity type
Higher or Secondary Education Establishments
FUNDACAO PIO XII
Brazil
EU contribution
€ 0
Address
Rua Antenor Duarte Vilela, 1331
Barretos
Activity type
Research Organisations
UNIVERSITAT ROVIRA I VIRGILI
Spain
EU contribution
€ 341 802,50
Address
Carrer De Escorxador
43003 Tarragona
Activity type
Higher or Secondary Education Establishments
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
Germany
EU contribution
€ 214 577,50
Address
Hansastrasse 27C
80686 Munchen
Activity type
Research Organisations
LABMAN AUTOMATION LIMITED
United Kingdom
EU contribution
€ 395 420
Address
Seamer Hill Stokesley
TS9 5NQ Middlesbrough Cleveland
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
MICROLIQUID SL
Spain
EU contribution
€ 151 605
Address
Avenida Uribarri 19-1 Saiolan
20500 Arrasate Mondragon
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)